Please login to the form below

Not currently logged in
Email:
Password:

infrastructure

This page shows the latest infrastructure news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

There will be no change to Lilly’s commercial infrastructure in Basingstoke, it says.

Latest news

More from news
Approximately 0 fully matching, plus 286 partially matching documents found.

Latest Intelligence

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    We need to see the big picture.”. Poor infrastructure is holding the UK back. ... Richard said the country is crying out for east- west rail and road transport infrastructure to link Oxford and Cambridge – getting between the two academic hotspots by

  • The evolution of real-world studies The evolution of real-world studies

    The MHRA hopes the trial will “attract global attention” and “be the first of many” such studies run on CPRD infrastructure. ... value. Other organisations think infrastructure shortcomings are preventing the collection and analysis of the robust

  • Real-world studies Real-world studies

    With the right technology, infrastructure and support, RWD can be collected, stored, analysed and reported, bringing the benefits of RWE to clinical research and commercialisation decision-making.

  • The social dilemma: is it time for pharma to join the party?

    That requires infrastructure and investment to ensure the conversations they have are ethical, professional and productive. ... We need a similar evolution in communication. Tomorrow’s leaders will likely be those that invest in a similar level of

  • 25 Women Leaders in UK Healthcare (part 2) 25 Women Leaders in UK Healthcare (part 2)

    The high cost of these treatments, and the need for entirely new healthcare infrastructures to ensure they reach patients is an enormous challenge for Gilead and for the NHS.

More from intelligence
Approximately 1 fully matching, plus 96 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 46 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

Empowering Strategic Performance helps clients Metamorph™ Science into Action that changes healthcare so improving the lives of patients. We help...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics